92 related articles for article (PubMed ID: 27323894)
1. Base excision repair pathway: PARP1 genotypes as modulators of therapy response in cervical cancer patients.
Nogueira A; Assis J; Faustino I; Pereira D; Catarino R; Medeiros R
Biomarkers; 2017 Feb; 22(1):70-76. PubMed ID: 27323894
[TBL] [Abstract][Full Text] [Related]
2. Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1.
Yosunkaya E; Kucukyuruk B; Onaran I; Gurel CB; Uzan M; Kanigur-Sultuybek G
Br J Neurosurg; 2010 Oct; 24(5):561-5. PubMed ID: 20868244
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
Zhao W; Hu L; Xu J; Shen H; Hu Z; Ma H; Shu Y; Shao Y; Yin Y
Cancer Chemother Pharmacol; 2013 May; 71(5):1287-95. PubMed ID: 23479135
[TBL] [Abstract][Full Text] [Related]
4. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
[TBL] [Abstract][Full Text] [Related]
5. Role of the RAD51 G172T polymorphism in the clinical outcome of cervical cancer patients under concomitant chemoradiotherapy.
Nogueira A; Catarino R; Faustino I; Nogueira-Silva C; Figueiredo T; Lombo L; Hilário-Silva I; Pereira D; Medeiros R
Gene; 2012 Aug; 504(2):279-83. PubMed ID: 22634097
[TBL] [Abstract][Full Text] [Related]
6. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
7. PARP1: A potential biomarker for gastric cancer.
Afzal H; Yousaf S; Rahman F; Ahmed MW; Akram Z; Akhtar Kayani M; Mahjabeen I
Pathol Res Pract; 2019 Aug; 215(8):152472. PubMed ID: 31174925
[TBL] [Abstract][Full Text] [Related]
8. Involvement of PARP-1 Val762Ala polymorphism in the onset of cervical cancer in caucasian women.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Diagn Ther; 2013 Aug; 17(4):239-45. PubMed ID: 23633189
[TBL] [Abstract][Full Text] [Related]
9. The impact of GGH -401C>T polymorphism on cisplatin-based chemoradiotherapy response and survival in cervical cancer.
Silva IH; Nogueira-Silva C; Figueiredo T; Lombo L; Faustino I; Catarino R; Nogueira A; Pereira D; Medeiros R
Gene; 2013 Jan; 512(2):247-50. PubMed ID: 23107767
[TBL] [Abstract][Full Text] [Related]
10. Let-7e Suppresses DNA Damage Repair and Sensitizes Ovarian Cancer to Cisplatin through Targeting PARP1.
Xiao M; Guo J; Xie L; Yang C; Gong L; Wang Z; Cai J
Mol Cancer Res; 2020 Mar; 18(3):436-447. PubMed ID: 31722968
[TBL] [Abstract][Full Text] [Related]
11.
Xin Y; Yang L; Su M; Cheng X; Zhu L; Liu J
J Int Med Res; 2021 Mar; 49(3):300060521992956. PubMed ID: 33706586
[TBL] [Abstract][Full Text] [Related]
12. PARP1 rs1136410 C/C genotype associated with an increased risk of esophageal cancer in smokers.
Zhou R; Li Y; Wang N; Niu C; Huang X; Cao S; Huo X
Mol Biol Rep; 2021 Feb; 48(2):1485-1491. PubMed ID: 33528729
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
14. Nuclear PARP1 expression and its prognostic significance in breast cancer patients.
Mazzotta A; Partipilo G; De Summa S; Giotta F; Simone G; Mangia A
Tumour Biol; 2016 May; 37(5):6143-53. PubMed ID: 26614429
[TBL] [Abstract][Full Text] [Related]
15. Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma.
Bashir K; Sarwar R; Saeed S; Mahjabeen I; Kayani MA
PLoS One; 2018; 13(9):e0199007. PubMed ID: 30183716
[TBL] [Abstract][Full Text] [Related]
16. Variants of Base Excision Repair Genes MUTYH , PARP1 and XRCC1 in Alzheimer's Disease Risk.
Kwiatkowski D; Czarny P; Galecki P; Bachurska A; Talarowska M; Orzechowska A; Bobińska K; Bielecka-Kowalska A; Pietras T; Szemraj J; Maes M; Sliwinski T
Neuropsychobiology; 2015; 71(3):176-86. PubMed ID: 25998844
[TBL] [Abstract][Full Text] [Related]
17. Relationship between clinical toxicities and ERCC1 rs3212986 and XRCC3 rs861539 polymorphisms in cervical cancer patients.
Soares S; Nogueira A; Coelho A; Assis J; Pereira D; Bravo I; Medeiros R
Int J Biol Markers; 2018 Jan; 33(1):116-123. PubMed ID: 28708208
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer.
Kim M; Kang HG; Lee SY; Lee HC; Lee EB; Choi YY; Lee WK; Cho S; Jin G; Jheon HS; Son JW; Lee MH; Jung DK; Cha SI; Kim CH; Kang YM; Kam S; Jung TH; Jheon S; Park JY
Cancer Sci; 2010 Nov; 101(11):2436-42. PubMed ID: 20731661
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase 1 regulates activity of DNA polymerase beta in long patch base excision repair.
Sukhanova M; Khodyreva S; Lavrik O
Mutat Res; 2010 Mar; 685(1-2):80-9. PubMed ID: 19703477
[TBL] [Abstract][Full Text] [Related]
20. The role of base excision repair in pathogenesis of breast cancer in the Polish population.
Cuchra M; Mucha B; Markiewicz L; Przybylowska-Sygut K; Pytel D; Jeziorski A; Kordek R; Majsterek I
Mol Carcinog; 2016 Dec; 55(12):1899-1914. PubMed ID: 27870262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
